GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ECS Botanics Holdings Ltd (ASX:ECS) » Definitions » EPS (Diluted)

ECS Botanics Holdings (ASX:ECS) EPS (Diluted) : A$-0.00 (TTM As of Dec. 2024)


View and export this data going back to 1986. Start your Free Trial

What is ECS Botanics Holdings EPS (Diluted)?

ECS Botanics Holdings's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was A$-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.00.

ECS Botanics Holdings's EPS (Basic) for the six months ended in Dec. 2024 was A$-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.00.

ECS Botanics Holdings's EPS without NRI for the six months ended in Dec. 2024 was A$-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.00.

During the past 12 months, ECS Botanics Holdings's average EPS without NRIGrowth Rate was -133.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, ECS Botanics Holdings's highest 3-Year average EPS without NRI Growth Rate was 86.80% per year. The lowest was -121.70% per year. And the median was 38.40% per year.


ECS Botanics Holdings EPS (Diluted) Historical Data

The historical data trend for ECS Botanics Holdings's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ECS Botanics Holdings EPS (Diluted) Chart

ECS Botanics Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.01 - - -

ECS Botanics Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ECS Botanics Holdings's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, ECS Botanics Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ECS Botanics Holdings's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ECS Botanics Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where ECS Botanics Holdings's PE Ratio falls into.


;
;

ECS Botanics Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

ECS Botanics Holdings's Diluted EPS for the fiscal year that ended in Jun. 2024 is calculated as

Diluted EPS (A: Jun. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1.99-0)/1243.868
=0.00

ECS Botanics Holdings's Diluted EPS for the quarter that ended in Dec. 2024 is calculated as

Diluted EPS (Q: Dec. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.98-0)/1289.202
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ECS Botanics Holdings  (ASX:ECS) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


ECS Botanics Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of ECS Botanics Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


ECS Botanics Holdings Business Description

Traded in Other Exchanges
N/A
Address
899 River Road, Murrabit West, Murrabit, VIC, AUS, 3579
ECS Botanics Holdings Ltd an Australian medicinal cannabis cultivator and manufacturer located in Northwest Victoria. ECS utilizes progressive cultivation methodologies to produce quality medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. Licensed by the Therapeutic Drug Administration to manufacture PIC/S GMP certified products, ECS provides of quality, affordable medicinal cannabis supplying both local and overseas markets.

ECS Botanics Holdings Headlines

No Headlines